3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
2
Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pseudomyxoma Peritonei
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Melanoma
1
Lymphoma, B-Cell
1
Lymphoma
1
Kidney Transplantation
1
Digestive System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Adenocarcinoma, Clear Cell
1
Interventions
Cyclophosphamide
22
Dexamethasone
15
Cytarabine
14
venetoclax
13
Vincristine
13
Methotrexate
10
Etoposide
10
Prednisone
9
Doxorubicin
9
Calcium Dobesilate
9
prednylidene
8
dexamethasone acetate
8
dexamethasone 21-phosphate
8
deltacortene
8
auricularum
8
merphos
7
Specimen Handling
7
pegaspargase
6
fludarabine phosphate
6
daratumumab
6
calaspargase pegol
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
fludarabine
5
Stem Cell Transplantation
5
Filgrastim
5
Daunorubicin
5
Bortezomib
5
Biopsy
5
Asparaginase
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Alemtuzumab
×
1 year
×
Clear all
No trials found.